Ontario man says medication he's been taking for a decade just quadrupled in price
An Ontario man with Duchenne muscular dystrophy said he was shocked when he got his latest prescription filled for a medication he has been taking for the past ten years.
“I couldn’t believe it. I need to take this medication to help my muscles be able to work a bit better and it has almost quadrupled in price,” said 21-year-old Arun Crishanth of Aurora.
The medication is Deflazacort, a popular drug used to treat Duchenne muscular dystrophy, however it is not covered under government health plans.
The drug is a steroid taken daily to help keep muscles strong and symptoms of muscular dystrophy in check.
Crishanth said he used to get a four month supply of Deflazacort for $187, but when he got his last prescription filled it jumped to $666.
Crishanth was told by his pharmacy Pharmasave that the price increase was due to it being manufactured by a new drug company.
“This new company decided to turn around and quadruple the price. To me it seems ridiculous that they can increase the price that much," said Crishanth.
CTV News Toronto reached out to Pharmasave and a spokesperson said, “Pharmacy pricing in Canada is linked to the cost to purchase the medication from the manufacturer or distributor. The increased pricing experienced by pharmacies (and thus also to patients) is due to manufacturer and distributor changes.”
Deflazacort, a popular drug used to treat Duchenne muscular dystrophy, is photographed.
CTV News Toronto also reached out to Muscular Dystrophy Canada and its CEO Stacey Lintern said in a statement, “Many individuals and their families have been advised by their doctors that Deflazacort is the most suitable option due to its minimal side effects, with some individuals having been on this treatment for 15 years or more. However, the significant increase in price will have detrimental effects on these individuals and their families.”
CTV News Toronto was unable to reach the new manufacturer of Deflazacourt, however Muscular Dystrophy Canada confirmed the price increase was due to a new manufacturer making the drug in Europe which also means increased shipping costs.
While there are cheaper alternatives, they have side effects and many patients with Duchenne muscular dystrophy feel that Deflazacourt is the preferred treatment.
"It’s a drug I’ve been taking for so many years, since I was 10 years old," said Crishanth, who said the drug will now cost him almost $2,000 a year.
"Obviously they should not be able to increase prices like that. It clearly isn't because of inflation, this is just to make some money and I think it's ridiculous that that can happen," said Crishanth.
Muscular Dystrophy Canada said it's important for patients to have equal access to appropriate treatments at a fair cost and that they will continue to try and influence change with regards to the price hike.
If you or your child is experiencing challenges accessing Deflazacort, you can contact Muscular Dystrophy Canada at research@muscle.ca or call 1-800-567-2873 ext. 1114.
CTVNews.ca Top Stories

Details leading up to Hardeep Singh Nijjar's death revealed
A long-time, close friend of Hardeep Singh Nijjar says the Sikh activist found a tracking device underneath his car before he was killed outside the Guru Nanak Sikh Gurdwara in June.
Disney+ following Netflix's lead in crack down on password sharing in Canada
Streaming platform Disney+ is updating its subscriber agreement and is adding a no-sharing passwords policy.
Hyundai and Kia recall nearly 3.4 million U.S. vehicles due to fire risk and urge owners to park outdoors
Hyundai and Kia are recalling nearly 3.4 million vehicles and telling owners to park them outside due to the risk of engine compartment fires.
U.S. soldier who sprinted into North Korea 2 months ago is in American custody, officials say
The U.S. soldier who sprinted into North Korea across the heavily fortified border between the Koreas two months ago was released into American custody Wednesday, according to two officials.
Hundreds of derelict vessels removed from Canadian waters, Coast Guard says
The Canadian Coast Guard is working its way through a Wrecked, Abandoned or Hazardous Vessels Act inventory, armed with the power to fine owners of vessels that threaten marine environments or public safety.
Ontario widower stuck with US$100K+ medical bill after late wife hospitalized on vacation
An Ontario widower, still grieving his wife's death, is unsure how to pay for a medical bill from their last vacation to Florida, which costs more than US$124,000.
Alberta government to give update on investigation into E. coli outbreak in Calgary
The Alberta government is to provide an update today on the investigation into an E. coli outbreak that affected multiple Calgary daycares.
ER doctor challenging 'toxic environment' in Ontario hospital after secret investigation based on unfounded murder allegation
After more than 30 years of caring for critically ill patients in emergency and intensive care, Dr. Scott Anderson is preparing to face off against the hospital where he works in London, Ont., in a case described as "unusual" by lawyers and potentially costly for Ontario taxpayers.
Former Spain women's national team coach Jorge Vilda added to probe into Rubiales' kissing a player
Former Spain women's national team coach Jorge Vilda has been summoned to appear before a judge in the probe involving former soccer federation president Luis Rubiales for his kissing a player on the lips after the team won the Women's World Cup title last month, court officials said Wednesday.